Tag: GlobeNewswire

In accordance with section 30 of the Capital Markets Act, Tryg A/S (“Tryg”) hereby announces that BlackRock, Inc. has notified Tryg that BlackRock, Inc. holds shares and voting rights, in accordance with section 38 of the Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Capital Markets Act and financial instruments with similar economic effect according to section 39(2)(2) of the Capital Markets Act, corresponding to more than 5% of the entire share capital and voting rights of Tryg. Please see further details in the attached notification form.

Additional information

Contact information:

• Gianandrea Roberti, Head of Financial Reporting, SVP, +45 20 18 82 67, gianandrea.roberti@tryg.dk 
• Robin Hjelgaard Løfgren, Head of Investor Relations, +45 41 86 25 88, robin.loefgren@tryg.dk

Attachment

• 41_Notification of major shareholdings

In accordance with section 30 of the Capital Markets Act, Tryg A/S (“Tryg”) hereby announces that BlackRock, Inc. has notified Tryg that BlackRock, Inc. holds shares and voting rights, in accordance with section 38 of the Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Capital Markets Act and financial instruments with similar economic effect according to section 39(2)(2) of the Capital Markets Act, corresponding to more than 5% of the entire share capital and voting rights of Tryg. Please see further details in the attached notification form.

Additional information

Contact information:

• Gianandrea Roberti, Head of Financial Reporting, SVP, +45 20 18 82 67, gianandrea.roberti@tryg.dk 
• Robin Hjelgaard Løfgren, Head of Investor Relations, +45 41 86 25 88, robin.loefgren@tryg.dk

Attachment

• 41_Notification of major shareholdings

Luotea Plc
Stock exchange release
30 October 2026 at 10:30 a.m.

Luotea Oyj – Managers’ Transactions

____________________________________________

Person subject to the notification requirement

Name: Antti Niitynpää

Position: Chief Executive Officer

Issuer: Luotea Oyj

LEI: 743700Z9Z54VGHZA0028

Notification type: INITIAL NOTIFICATION

Reference number: 178244/6/6

____________________________________________

Transaction date: 2026-10-29

Venue: NASDAQ HELSINKI LTD (XHEL)

Instrument type: SHARE

ISIN: FI4000592464

Nature of transaction: ACQUISITION

Transaction details

(1): Volume: 5149 Unit price: 1.948 EUR

(2): Volume: 25 Unit price: 1.948 EUR

(3): Volume: 170 Unit price: 1.948 EUR

(4): Volume: 18 Unit price: 1.948 EUR

(5): Volume: 138 Unit price: 1.948 EUR

Aggregated transactions (5):

Volume: 5500 Volume weighted average price: 1.948 EUR

LUOTEA PLC

Heikki Eskola
General Counsel

Further information:
Heikki Eskola, +358 50 586 5907, heikki.eskola@luotea.com

Distribution:
Nasdaq Helsinki
Main media
www.luotea.com

Luotea is a pioneer in facility services, offering comprehensive lifecycle solutions for buildings. We combine energy efficiency with innovative thinking to maximise property value and ensure the best conditions for every user. Our services range from advanced property maintenance, building technology and consultancy to professional cleaning and support. We grow sustainably and profitably, mindful of our impact on buildings, the environment and society. Leading the way, we drive our industry forward and shape a better tomorrow. For us, success is measured in trust – the trust our people, clients and owners have in us.

Luotea operates in Finland and Sweden, with 2025 net sales EUR 346 million and a workforce of approximately 5,000. Luotea is publicly listed on Nasdaq Helsinki.

• This international award, honoring “the best of the best” in medical innovation, represents yet another important external recognition of AI-Immunology™

COPENHAGEN, Denmark, October 30, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, is proud to have been awarded the 2026 International Prix Galien Award for AI-Immunology™ as best digital health solution. It is the first time the prestigious international award has been won by a Danish company.

Evaxion CEO Helen Tayton-Martin and founder and Chief AI Officer Andreas Holm Mattsson received the award last night at the American Museum of Natural History in New York City. It represents yet another important external recognition of AI-Immunology™, which harnesses the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer as well as infectious and autoimmune diseases.

AI-Immunology™ is Evaxion’s proprietary, clinically validated and scalable AI platform with which it conducts rapid, efficient and high-quality target discovery, drug design and development. Evaxion has discovered and designed several potential new drug candidates with AI-Immunology™, the furthest developed being its personalized cancer vaccine EVX-01. As recently as last week, three-year data from a phase 2 trial with EVX-01, reflecting durable clinical outcomes and immune system activation in advanced melanoma patients was presented at the European Society for Medical Oncology Congress in Madrid.

“The International Prix Galien Award is a tremendous recognition of our science and technology, which we are honored and delighted to receive. Having been refined, trained and enhanced for almost two decades, AI-Immunology™ is a leading and clinically validated platform for novel immune drug target discovery, especially in cancer vaccines. We are delighted by this distinction, which strongly endorses our approach in leveraging AI to develop new treatments,” says Helen Tayton-Martin.

The International Prix Galien Award is presented every two years with eligible nominees having received a national Prix Galien award within the last two years. Thus, it honors “the best of the best” within different categories of medical innovation. Worldwide, the Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

Evaxion won the Prix Galien UK Award for Best digital health solution in June 2026 and the award for the Best Medical Technology/AI Advances in the Nordic and high-growth European and Middle Eastern countries in December 2025.

Founded in France 50 years ago by pharmacist Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien supports, recognizes and awards the efforts of scientists, researchers and companies committed to advancing medical innovation with the power to change the human condition.

Contact information
Evaxion A/S
Mads Kronborg
Vice President, Investor Relations & Communication
+45 53 54 82 96
mak@evaxion.ai

About Evaxion
Evaxion is a pioneering clinical-stage TechBio company based upon its proprietary, clinically validated and scalable AI platform, AI-Immunology™. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer as well as infectious and autoimmune diseases.

With AI-Immunology™ we conduct rapid, efficient and high-quality target discovery, drug design and development. Our team of +40 experts covers the entire value chain from target discovery to clinical development.

We have developed a pipeline of both personalized and off-the-shelf cancer vaccine candidates as well as prophylactic vaccine candidates for infectious diseases. All our candidates address high unmet medical needs, reflecting our commitment to transforming patients’ lives by providing innovative and targeted treatment options.

For more information about Evaxion, AI-Immunology™ and our pipeline, please visit our website. 

Forward-looking statement 
This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “target,” “believe,” “expect,” “hope,” “aim,” “intend,” “may,” “might,” “anticipate,” “contemplate,” “continue,” “estimate,” “plan,” “potential,” “predict,” “project,” “will,” “can have,” “likely,” “should,” “would,” “could,” and other words and terms of similar meaning identify forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including, but not limited to, risks related to: our financial condition and need for additional capital; our development work; cost and success of our product development activities and preclinical and clinical trials; commercializing any approved pharmaceutical product developed using our AI platform technology, including the rate and degree of market acceptance of our product candidates; our dependence on third parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing growth; our ADSs and ordinary shares, the impact of international economic, political, legal, compliance, social and business factors, including inflation, and the effects on our business from other significant geopolitical and macro-economic events; and other uncertainties affecting our business operations and financial condition. For a further discussion of these risks, please refer to the risk factors included in our most recent Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission (SEC), which are available at www.sec.gov. We do not assume any obligation to update any forward-looking statements except as required by law. 

Med virkning fra den 30. oktober 2026 offentliggøres prospekt for Investeringsforeningen Nordea Invest.
Prospektet er opdateret med følgende ændringer for Virksomhedsobligationer Højrente KL 1:

• ændring af benchmark
• opdateret risikovurdering
• opdaterede oplysninger om forvalteren

Prospektet kan findes på https://www.nordeafunds.com/da/vores-fonde

Med venlig hilsen
Nordea Fund Management, filial af Nordea Funds Oy, Finland
Tim Galberg-Lund
Filialbestyrer

Jyske Bank A/S’ acquisition of FP Kapital A/S (Formuepleje) will be completed with effect from 2 November 2026.
                                  
Yours faithfully,                         
Jyske Bank

Contact: Birger Krøgh Nielsen, CFO, tel. +45 25 26 92 42.

Attachment

• Formuepleje becomes part of the Jyske Bank Group

The INVL Baltic Sea Growth Fund, the leading private equity fund in the Baltics, has announced that its portfolio company, Galinta, one of the largest buckwheat producers in Europe and a major producer of cereal flakes in the Baltics, has signed an agreement to acquire 100% of the shares in the Estonian company Worldline. The company produces packaged rice, groats, and other cereal products under the ‘Baltix’ brand.

“With this acquisition, Galinta strengthens its position in Estonia and gains a well-established producer with a brand that is familiar to consumers. We also see tangible synergies in raw material procurement, production, and logistics,” says Aurimas Taraškevičius, CEO of Galinta.

‘Baltix’ is one of the top three brands in its category in the country, and its products are sold in all major Estonian retail chains.

In 2025, the Galinta Group’s revenue amounted to EUR 37.9 million. The acquisition will add approximately EUR 2.1 million in annual revenue to the Galinta Group.

The transaction is expected to be completed by the end of this year, subject to approval from the Estonian Competition Authority and the fulfilment of other customary closing conditions.

About the INVL Baltic Sea Growth Fund

With a fund size of EUR 165 million, the INVL Baltic Sea Growth Fund is one of the leading private equity funds in the Baltics. Its anchor investor is the European Investment Fund (EIF), which is a part of the European Investment Bank and committed EUR 30 million with the support of the European Fund for Strategic Investments (a key element of the Investment Plan for Europe, or the Junker Plan) while also allocating resources from the Baltic Innovation Fund (a “fund of funds” initiative developed in cooperation with the governments of Lithuania, Latvia and Estonia,  to increase capital investment in high-growth potential small and medium-sized enterprises in the Baltics).

The fund is managed by INVL Asset Management, the leading Baltic alternative asset manager, which is a part of the Invalda INVL Group with over 30 years of experience. The group’s companies manage or have under supervision EUR 2.3 billion in assets across various investment strategies, including private equity, forests and agricultural land, renewable energy, real estate, and private debt. Additionally, the group provides family office services in Lithuania, Latvia and Estonia, manages pension funds in Latvia, and invests in global third-party funds.

About Galinta

Galinta is one of the largest producers and traders of buckwheat, rice and other groats in the Baltic region, whose 100% of shares were acquired by INVL Baltic Sea Growth Fund in February 2024. Having started its operations in 1997 as a trader of grain grown by Lithuanian farmers, the company today supplies its products not only to Baltic consumers but also to customers in the United States, the United Kingdom and Scandinavia. During the fund’s management period, the company has been pursuing an active expansion strategy in the region — in 2025 it acquired Lithuanian buckwheat groats producer Ekofrisa, thereby strengthening its market position.

About Worldline

The company began its operations in 1997 by supplying grain products to various food industry manufacturers and packers. Six years later, having acquired packaging equipment, the company started packaging its own products as well. That same year, the well-known brand Baltix was introduced, which quickly gained consumer recognition.

Today the company supplies products both to the HoReCa sector and to food industry companies in Estonia and beyond, with its clients including not only local but also Finnish and Latvian retail chains. Its core business remains the import, export and packaging of grain products, while for those with a sweet tooth, the company additionally offers a variety of cupcakes, cookies and other treats.

Further information:
Deimantė Korsakaitė
the Executive Partner of the INVL Baltic Sea Growth Fund
deimante.korsakaite@invl.com 

Press release                                                                                                                Paris, October 30, 2026

Activity driven by all business lines

9M 2026 KEY FIGURES:

• Total premium income¹ at €44.4 billion, up +12.8%²
• Net inflows³ at +€15.0 billion of which +€3.2 billion in Q3

Nicolas Denis, Chief Executive Officer of Crédit Agricole Assurances, said:
“As a leading insurer, we are, with our teams, and those of our banking partners, fully mobilized to protect our customers and territories from the consequences of geopolitical, climate and societal risks that have reached unprecedented levels in recent months. In this demanding context, the strength of our results confirms our ability to fulfill our missions over the long term and for all our fellow citizens. The nearly 13% growth of our premium income, which reached €44.4 billion, reflects society’s need for protection and the confidence placed in us by our customers. Our contribution to the pre-tax income of Crédit Agricole S.A. group continues to grow by 2.1%, reaching €1.947 billion, despite high claims related to climate events. These strong results also confirm the soundness of our development and transformation strategy “Shape Tomorrow”, recently illustrated by the launch of Crédit Agricole Insurance Partners and the integration of Milleis Vie.
It enables us above all to be present in all circumstances alongside our customers, in their projects as well as in difficult times. Being strong to be useful: this is the essence of our model and our commitment.”

DOUBLE-DIGIT GROWTH ACROSS ALL BUSINESS LINES

Over the first nine months of the year, Crédit Agricole Assurances generated a total premium income¹ of €44.4 billion, up +12.8%² compared with the end of September 2025. The momentum is driven by all business lines.

In savings and retirement, premium income¹ reached €33.9 billion at the end of September 2026, up +13.6% year-on-year. Preferential profit-sharing offers (PAB) on euro payments that ended on September 30 stimulated gross inflows³. They amounted to €22.3 billion (+12.7%) on General Account and €11.6 billion on Unit-Linked products (+15.3%). As a result, the share of Unit-Linked within gross inflows stood at 34.2% (+0.5 point year on-year).

Net inflows³ amounted to +€15.0 billion, up +€3.0 billion year-on-year. Net inflows³ reached +€8.0 billion on the General Account (+€1.7 billion year-on-year) and +€7.0 billion on Unit-Linked (+€1.3 billion year-on-year).

Life insurance assets under management⁴ reached €395.8 billion at the end of September 2026 (+7.9% year-on-year) thanks to very strong net inflows³ and a favorable market and capitalization effect over the period. They included €270.5 billion on the General Account (+6.3% over one year) and €125.3 billion on Unit-Linked (+11.7% year-on-year). As a result, Unit-Linked reserves represented 31.6% of total life insurance outstandings at the end of September 2026, up +1.1 points compared to December 31, 2025.

In property and casualty⁵, activity continued its growth trajectory with premium income¹ up by +10.1% compared to the end of September 2025, reaching €5.9 billion, including PiùVera Assicurazioni which was not consolidated in Q3 2025. At constant scope, the increase was +7.9%. The portfolio amounted to 18.3 million contracts, growing +6.4% year-on-year (+2.6% at constant scope).

Equipment rates within the Crédit Agricole Group banks kept growing year-on-year, both in Regional Banks (45.3%⁶, up +0.7 point), LCL (29.1%⁶, up +0.5 point), and CA Italia (21.2%⁷, up +0.6 point).

In personal protection (death and disability / creditor / group insurance⁸), premium income¹ amounted to €4.6 billion, up +10.7% year-on-year, including PiùVera Assicurazioni and PiùVera Protezione which were not consolidated in Q3 2025. At constant scope, premium income growth was +6.4%. Creditor insurance grew by +8.6% (+2.2% at constant scope), both on consumer credit and mortgage credit. Individual death and disability grew by +11.0% (+9.2% at constant scope), while group insurance was dynamic at +20.0%.

In individual and group health⁹, premium income¹ kept growing at +14.8% year-on-year (+12.7% at constant scope).

RESULTS DRIVEN BY SAVINGS AND RETIREMENT BUSINESS AND IMPACTED BY CLIMATE EVENTS

The first nine months of the year were impacted by severe weather events: storms, droughts, hailstorms, wildfires. However, growth in savings and retirement and favorable liquidations on prior year claims in property and casualty insurance helped to absorb the impact of these climate events. Consequently, Crédit Agricole Assurances’ contribution to Crédit Agricole S.A. group’s pre-tax income amounted to €1,947 million, up +2.1% year-on-year. Crédit Agricole Assurances’ contribution to Crédit Agricole S.A.’s net income Group share declined by -1.2% year-on-year to €1,443 million, due to an unfavorable base effect on corporate income tax.

As a result of the climate events that occurred since the beginning of the year, the combined ratio¹⁰ increased by +1.8 points year-on-year to stand at 97.2%. The undiscounted net combined ratio increased by +2.5 points, at 100.1%.

The contractual service margin stood at €27.9 billion at end of September 2026, up +1.6% compared to the end of December 2025. It included a strong contribution from new business, exceeding the CSM release through P&L, that helped to offset the less favorable market conditions affecting the stock revaluation in the third quarter.

RATINGS

Rating agency	Date of the last decision	Main operating subsidiaries	Crédit Agricole Assurances S.A.	Outlook	Subordinated debt
					Tier 2	Restricted Tier 1
S&P Global Ratings	October 1, 2026	A+	A	Stable	BBB+	BBB

HIGHLIGHTS SINCE THE LAST PUBLICATION

• Crédit Agricole Assurances makes an initial investment of €100 million in a tokenized Amundi fund in collaboration with CACEIS
• Crédit Agricole Assurances makes Creditor and Death&Disability Insurance more accessible for people living with HIV
• Crédit Agricole Assurances has successfully priced 750 million euros of Tier 2 subordinated notes at a fixed annual interest rate of 5.125% under its EMTN programme
• Release of Crédit Agricole Assurances Investor Presentation – September 2026 (HY-26 figures)
• Crédit Agricole Assurances et Crédit Agricole Transition & Energy launch their new innovation challenge dedicated to risk prevention and sustainable reconstruction

About Crédit Agricole Assurances
Crédit Agricole Assurances, France’s leading insurer, is Crédit Agricole Group’s subsidiary, which brings together all the insurance businesses of Crédit Agricole S.A. Crédit Agricole Assurances offers a range of products and services in savings, retirement, health, personal protection and property insurance. They are distributed by Crédit Agricole’s banks in France and in 9 countries worldwide, and are aimed at individual, professional, agricultural and business customers. At the end of 2025, Crédit Agricole Assurances had more than 7,100 employees. Its 2025 premium income (non-GAAP) amounted to 52.4 billion euros.
www.ca-assurances.com/en/

Press contacts Géraldine Bailacq +33 (0)6 81 75 87 59 Nicolas Leviaux +33 (0)6 19 60 48 53 Julien Badé +33 (0)7 85 18 68 05 service.presse@ca-assurances.fr

Investors relations contacts Yael Beer-Gabel +33 (0)1 57 72 66 84 Gaël Hoyer +33 (0)1 57 72 62 22 Sophie Santourian +33 (0)1 57 72 43 42 Cécile Roy +33 (0)1 57 72 61 86 relations.investisseurs@ca-assurances.fr

---

1 « Non-GAAP » revenues
2 At constant scope, excluding the consolidation of PiùVera Assicurazioni and PiùVera Protezione (Italian 65%-owned subsidiaries, respectively active in property and personal protection, and personal protection insurance) on December 31, 2025, with retroactive effect at January 1, 2025, premium income growth would be +12.1%.
3 In local GAAP
4 Savings, Retirement and Protection (funeral)
5 As of September 30, 2026, PiùVera Assicurazioni property and casualty portfolio stood at 658k contracts, including net contribution of +25k contracts year-on-year.
6 Percentage of Regional Banks and LCL customers with at least one motor, home, health, legal, mobile/portable or personal accident insurance policy marketed by Pacifica, French Crédit Agricole Assurances’ non-life insurance subsidiary.
7 Percentage of CA Italia network customers with at least one policy marketed by CA Assicurazioni, Italian Crédit Agricole Assurances’ non-life insurance subsidiary
8 Excluding savings and retirement
9 Health revenue is split between property and casualty for the individual segment and group insurance for the collective segment.
10 See definition in chapter 8.4 “Alternative Performance Indicator (API)” of Crédit Agricole Assurances’ 2025 Universal Registration Document available on Investors – Crédit Agricole Assurances Institutional Website

Attachment

• Press release – CAA 9M 2026 results

Update on the Share Buyback Program and the Liquidity Agreement

Period from 22 October 2026 to 28 October 2026

Share Buyback Program
On 26 February 2026, Bekaert announced the start of the next tranche of its share buyback program, for a total maximum consideration of up to € 75 million. As announced previously, the purpose of the Program is to cancel all shares repurchased.

Bekaert announces today that during the period from 22 October 2026 to 28 October 2026, Kepler Cheuvreux SA on behalf of Bekaert has bought 36 361 shares.

The table below provides an overview of the transactions under the Program during the period from 22 October 2026 to 28 October 2026:

	Repurchase of shares
Date	Market	Number of Shares	Average Price paid (€)	Highest Price paid (€)	Lowest Price paid (€)	Total Amount (€)
22 October 2026	Euronext Brussels	4 411	40.74	40.95	40.30	179 704
	MTF CBOE	3 450	40.74	41.00	40.30	140 553
	MTF Turquoise
	MTF Aquis
23 October 2026	Euronext Brussels	4 052	40.44	41.00	39.95	163 863
	MTF CBOE	2 948	40.44	41.00	40.00	119 217
	MTF Turquoise
	MTF Aquis
26 October 2026	Euronext Brussels	3 964	40.47	40.60	40.25	160 423
	MTF CBOE	3 036	40.47	40.55	40.25	122 867
	MTF Turquoise
	MTF Aquis
27 October 2026	Euronext Brussels	4 799	40.56	40.80	40.00	194 647
	MTF CBOE	2 201	40.43	40.80	40.10	88 986
	MTF Turquoise
	MTF Aquis
28 October 2026	Euronext Brussels	5 294	40.29	40.65	39.95	213 295
	MTF CBOE	2 206	40.29	40.65	39.95	88 880
	MTF Turquoise
	MTF Aquis
Total		36 361	40.49	41.00	39.95	1 472 435

Liquidity agreement
In relation to the renewed liquidity agreement with Kepler Cheuvreux announced on 25 June 2024, Bekaert announces today that Kepler Cheuvreux on behalf of Bekaert has bought 3 200 shares during the period from 22 October 2026 to 28 October 2026 on Euronext Brussels. During the same period, Kepler Cheuvreux on behalf of Bekaert has sold 2 200 shares on Euronext Brussels.

The tables below provide an overview of the transactions under the liquidity agreement during the period from 22 October 2026 to 28 October 2026:

	Purchase of shares
Date	Number of Shares	Average Price (€)	Highest Price (€)	Lowest Price (€)	Total Amount (€)
22 October 2026	1 000	40.60	40.80	40.40	40 600
23 October 2026	800	40.30	40.60	40.00	32 240
26 October 2026	0	0.00	0.00	0.00	0
27 October 2026	400	40.10	40.10	40.10	16 040
28 October 2026	1 000	40.29	40.55	40.00	40 290
Total	3 200				129 170

	Sale of shares
Date	Number of Shares	Average Price (€)	Highest Price (€)	Lowest Price (€)	Total Amount (€)
22 October 2026	200	41.00	41.00	41.00	8 200
23 October 2026	600	40.87	41.20	40.60	24 522
26 October 2026	400	40.50	40.60	40.40	16 200
27 October 2026	800	40.58	40.80	40.40	32 464
28 October 2026	200	40.75	40.75	40.75	8 150
Total	2 200				89 536

The balance held by Bekaert under the liquidity agreement at the end of the period is 24 471 shares.

On 28 October 2026 after closing of the market, Bekaert holds 1 832 461 own shares, or 3.71% of the total number of the outstanding shares.

This information is also made available on the investor relations pages of our website.

Attachment

• p261030E – Bekaert – Update on the Share Buyback Program and the Liquidity Agreement

SBA Group textile manufacturer Utenos Trikotažas reported revenue of EUR 15.3 million for the first nine months of 2026, up 2.4% year on year. Sales of its own apparel brand, UTENOS, increased by 21.3%. In the third quarter alone, the company’s revenue grew by 17.2%, while operating profit more than tripled compared with the same period last year.

“The third quarter is traditionally stronger in our industry, but what matters most is that we have improved on the same period last year. Growth was reflected not only in sales, but also in operating profit,” says Nomeda Kaučikienė, CEO of Utenos Trikotažas.

Third-quarter growth was primarily driven by contract knitwear manufacturing, with sales in this segment increasing by 17.8% to EUR 6.6 million. Sales in Scandinavian markets rose significantly, by 64.2%, while total export revenue increased by 14.6%.

Utenos Trikotažas recorded a net profit of EUR 0.3 million in the third quarter, compared with a net loss of EUR 0.9 million in the same period last year. For the nine-month period, the company narrowed its net loss from EUR 0.8 million to EUR 0.2 million. However, EBITDA declined to EUR 0.26 million, compared with EUR 0.67 million a year earlier.
Continued Focus on Own-Brand Development

The continued development of its own apparel brand, UTENOS, remains one of the company’s strategic growth priorities. Brand sales increased by 21.3% in the first nine months of 2026, reaching EUR 2 million.

“We are developing our own brand as a distinct business segment with long-term growth potential. To drive sales growth, we are refreshing our product range, strengthening our e-commerce and marketing capabilities, and actively collaborating with Lithuanian fashion designers,” says Nomeda Kaučikienė.

Continued uncertainty in the European textile industry, coupled with cautious production planning among international customers, reinforces the company’s focus on improving operational efficiency.

“We continue to systematically review operating costs, streamline management processes and allocate resources to areas with the greatest potential to create long-term value. Our third-quarter results indicate positive progress, but we remain cautious about market conditions and focused on achieving sustainable profitability,” notes Nomeda Kaučikienė.

About Utenos Trikotažas

Utenos Trikotažas is one of the largest and most sustainable knitwear manufacturers in Central and Eastern Europe. The Company specializes in the development of innovative materials and the production of garments for leading international brands, as well as the development of its own apparel brand, UTENOS. Utenos Trikotažas is part of the SBA Group.

Additional information is available from Gediminas Kudarauskas, CFO, tel. No. +370 616 33169.

Nomeda Kaučikienė, CEO of AB Utenos trikotažas

Attachments

• Ataskaita_ENG
• Confirmation_OfResp_EN